Behavioral Health Business December 23, 2024
The substance use disorder (SUD) treatment industry stands at a precipice as several regulations are set to transform the field in 2025.
Crucial telehealth policies hang in the balance after the Drug Enforcement Administration (DEA) kicked the can on COVID-era prescribing flexibilities, now set to expire at the end of 2025. Further deferrals or the revocation of these policies could destabilize what has become common practice in the SUD industry.
The changing of the guard at the White House also portends possible changes. A new head of Centers for Medicare & Medicaid Services – a post-President-elect Donald Trump has decided to fill with famed TV personality Dr. Mehmet Oz – could lead to “meaningful” changes in key Medicaid policies.
Much...
Today's Sponsors
Today's Sponsor